New daily tablet offers hope to MS youngsters

Experts have hailed the results of a trial of the drug Gilenya as ‘some of the most promising ever seen’ following a study of 215 children aged between ten and 17 from across the globe.

Source: the Mail online | Health - November 11, 2017 Category: Consumer Health News Source Type: news